Responses
EHDN Plenary Meeting: abstracts
Experimental therapeutics: preclinical
B12 Treatment with arimoclomol does not lead to rescue of motor or striatal deficits in the YAC128 mouse model of Huntington's disease
Compose a Response to This Article
Other responses
No responses have been published for this article.